Switch to:

Tekla Life Sciences Investors Cash-to-Debt

: N/A (As of Sep. 2020)
View and export this data going back to . Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Tekla Life Sciences Investors's cash to debt ratio for the quarter that ended in Sep. 2020 was N/A.

NYSE:HQL' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt   Med: No Debt   Max: No Debt
Current: N/A

During the past 4 years, Tekla Life Sciences Investors's highest Cash to Debt Ratio was No Debt. The lowest was No Debt. And the median was No Debt.

NYSE:HQL's Cash-to-Debt is ranked lower than
99.99% of the 1452 Companies
in the Asset Management industry.

( Industry Median: 16.14 vs. NYSE:HQL: N/A )

Tekla Life Sciences Investors Cash-to-Debt Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Tekla Life Sciences Investors Annual Data
Sep17 Sep18 Sep19 Sep20
Cash-to-Debt No Debt N/A No Debt N/A

Tekla Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20
Cash-to-Debt Premium Member Only Premium Member Only N/A N/A No Debt No Debt N/A

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Tekla Life Sciences Investors Cash-to-Debt Distribution

* The bar in red indicates where Tekla Life Sciences Investors's Cash-to-Debt falls into.



Tekla Life Sciences Investors Cash-to-Debt Calculation

This is the ratio of a company's Cash and cash equivalents to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Tekla Life Sciences Investors's Cash to Debt Ratio for the fiscal year that ended in Sep. 2020 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Tekla Life Sciences Investors's Cash to Debt Ratio for the quarter that ended in Sep. 2020 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Tekla Life Sciences Investors  (NYSE:HQL) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Tekla Life Sciences Investors Cash-to-Debt Related Terms


Tekla Life Sciences Investors Cash-to-Debt Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)